Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.1.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KJ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KJ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KJ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KJ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JC.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JC.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JC.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JC.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.625ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.625ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.625ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.625NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HD.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HD.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HD.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GY.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GY.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GY.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GY.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HH.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HH.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HH.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HH.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KN.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KN.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KN.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.43.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.43.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.43.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.43.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.332ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.332ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.332ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.332NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JB.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JB.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JB.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JB.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.86.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.86.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.86.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.86.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JW.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used